|
1 Indications And Usage Kengreal Is Indicated As An Adjunct To Percutaneous Coronary Intervention (Pci) To Reduce The Risk Of Periprocedural Myocardial Infarction (Mi), Repeat Coronary Revascularization, And Stent Thrombosis (St) In Patients Who Have Not Been Treated With A P2y 12 Platelet Inhibitor And Are Not Being Given A Glycoprotein Iib/iiia Inhibitor [See Clinical Studies ( 14.1 )]. Kengreal Is A P2y 12 Platelet Inhibitor Indicated As An Adjunct To Percutaneous Coronary Intervention (Pci) For Reducing The Risk Of Periprocedural Myocardial Infarction (Mi), Repeat Coronary Revascularization, And Stent Thrombosis (St) In Patients In Who Have Not Been Treated With A P2y 12 Platelet Inhibitor And Are Not Being Given A Glycoprotein Iib/iiia Inhibitor. ( 1 )
|